The most frequent aminoglycoside resistance mechanisms - changes with time and geographic area: A reflection of aminoglycoside usage patterns?

Clinical Infectious Diseases

Volumn 24, Issue 1 SUPPL., 1997, Pages

  Miller, G H ^a   Sabatelli, F J ^b   Hare, R S ^b   Glupczynski, Y ^b   Mackey, P ^b   Shlaes, D ^b   Shimizu, K ^b   Shaw, K J ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; HABEKACIN; ISEPAMICIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; CITROBACTER; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA; KLEBSIELLA; NONHUMAN; PRIORITY JOURNAL; PROTEUS; PROVIDENCIA; PSEUDOMONAS; SALMONELLA; SERRATIA; SHIGELLA; STAPHYLOCOCCUS;

ACINETOBACTER; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; ENTEROBACTERIACEAE; EUROPE; JAPAN; PROVIDENCIA; PSEUDOMONAS; SERRATIA; STAPHYLOCOCCUS; UNITED STATES;

EID: 0031021201     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.supplement_1.s46     Document Type: Article

References (11)

1. The Aminoglycoside Resistance Study Groups. The most frequently occurring aminoglycoside resistance mechanisms - combined results of surveys in eight regions of the world. J Chemother 1995;7(suppl 2):17-30.
2. Miller GH, Sabatelli FJ, Naples L, Hare RS, Shaw KJ, the Aminoglycoside Resistance Study Groups. The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin - a new broad-spectrum aminoglycoside. J Chemother 1995;7(suppl 2):31-44.
3. Shimizu K, Kumada T, Hsieh W-C, et al. Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile and the United States. Antimicrob Agents Chemother 1985;28:282-8.
4. Hare RS, Miller GH, Sabatelli FJ, Weiss WJ, Shlaes DM. Aminoglycoside (AG) usage and enzymatic mechanism of resistance [abstract 416]. In: Program and abstracts of the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1985:167.
5. Hare RS, Shaw KJ, Sabatelli FJ, et al. Survey of aminoglycoside resistance in 29 USA hospitals [abstract 675]. In: Program and abstracts of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1989.
6. Dornbusch K, European Study Group on Antibiotic Resistance. In vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in twenty-nine European laboratories. Eur J Clin Microbiol 1987;6:378-85.
7. Dornbusch K, Miller GH, Hare RS, Shaw KJ, the ESGAR Study Group. Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. J Antimicrob Chemother 1990;26:131-44.
8. The Belgian Ag R Study Group, Glupczynski Y, Miller GH, Sabatelli FJ, Hare RS, Shaw KJ. Changes in aminoglycoside (Ag) resistance (R) mechanisms (M) in Belgium over 15 years [abstract C124]. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1996.
9. Shimizu K, Nasu M, Tozuka K, Shaw K, Hare R, Miller G. Comparison of aminoglycoside (Ag) resistance patterns (AGRP's) in gram-negative bacteria (GNB) from the eastern (E) and western (W) areas of Japan [abstract 397]. In: Program and abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1987:166.
10. Price KE, Kresel PA, Farchione LA, Siskin SB, Karpow SA. Epidemiological studies of aminoglycoside resistance in the USA. J Antimicrob Chemother 1981;8(suppl A):89-105.
11. Rather PN, Orosz E, Shaw KJ, Hare R, Miller G. Characterization and transcriptional regulation of the 2′-N-acetyltransferase gene from Providencia stuartii. J Bacteriol 1993;175(20):6492-8.